Abortion Policy, Law & PoliticsNEWS OR ANALYSIS
How voters feel about trans rights and abortion access will soon be put to the test
How do voters feel about trans students participating in school sports teams? Or abortion access?
Read →Search & Filter
12 articles
Abortion Policy, Law & PoliticsNEWS OR ANALYSIS
STAT+: The key health care ballot measures we’re watching in the midterms
State fights over issues like transgender rights and Medicaid offer clues to where Americans stand on contentious health matters.
Read →Euthanasia, Assisted Suicide & End-of-Life CareNEWS OR ANALYSIS
Opinion: My mother killed herself. I wish assisted suicide had been an option
“Sometimes mental illness is terminal,” Torie Bosch writes in a personal essay about medical aid in dying for psychiatric reasons.
Read →Abortion Policy, Law & PoliticsNEWS OR ANALYSIS
The fall of Roe dramatically changed abortion access. This researcher used Reddit to capture how
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools without losing sight of the people behind the data.
Read →Abortion Drugs & PracticesNEWS OR ANALYSIS
FDA says its safety review of abortion pill will continue into next year
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was quickly condemned by abortion opponents.
Read →Abortion Drugs & PracticesNEWS OR ANALYSIS
Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
Heidi Overton, nominee for commissioner of the Food and Drug Administration, avoided directly addressing her views on mifepristone during a Senate health committee meeting. As CEO of Reproductive Futures, a legal organization advocating for reproductive rights, the author expresses concern that Overton's anti-abortion views could lead to harmful policies if she becomes FDA commissioner.
Read →Abortion Policy, Law & PoliticsNEWS OR ANALYSIS
STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing
Heidi Overton, President Trump's nominee to lead the FDA, was questioned by senators on topics including China, vaccines, and abortion access during her committee hearing. Overton, a preventive medicine physician from New Mexico, repeatedly referred to existing FDA guidance and approvals without revealing her personal stance on updating or altering them.
Read →Human Dignity, Disability & BioethicsNEWS OR ANALYSIS
Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more
“A click, signature, or brief review should not magically transfer responsibility from an AI developer or platform to a physician,” a reader tells STAT.
Read →Abortion Drugs & PracticesNEWS OR ANALYSIS
STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new report
The report raises a high-profile issue for Heidi Overton as she faces confirmation as FDA commissioner.
Read →Abortion Policy, Law & PoliticsNEWS OR ANALYSIS
Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of “Impossible Choices.”
Read →Euthanasia, Assisted Suicide & End-of-Life CareNEWS OR ANALYSIS
Opinion: Medical aid in dying and the burden of choosing to live
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.
Read →Human Dignity, Disability & BioethicsNEWS OR ANALYSIS
Opinion: 8 steps to making surrogacy more ethical for everyone involved
“Everything about the West case shows how miserably surrogacy has been managed in America,” writes Arthur Caplan.
Read →